DWT
GILD icon

Dorsey & Whitney Trust’s Gilead Sciences GILD Stock Holding History

Dorsey & Whitney Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Buy
13,273
+168
+1% +$23.5K 0.1% 184
2025
Q4 		$1.61M Buy
13,105
+1,018
+8% +$124K 0.09% 194
2025
Q3 		$1.34M Sell
12,087
-148
-1% -$16.8K 0.07% 219
2025
Q2 		$1.36M Sell
12,235
-371
-3% -$39.5K 0.07% 220
2025
Q1 		$1.41M Sell
12,606
-1,137
-8% -$117K 0.08% 212
2024
Q4 		$1.27M Buy
13,743
+209
+2% +$18.8K 0.07% 219
2024
Q3 		$1.13M Buy
13,534
+3,454
+34% +$264K 0.06% 237
2024
Q2 		$692K Sell
10,080
-2,533
-20% -$169K 0.05% 276
2024
Q1 		$924K Buy
12,613
+1,746
+16% +$134K 0.06% 230
2023
Q4 		$880K Buy
10,867
+58
+0.5% +$4.51K 0.07% 224
2023
Q3 		$810K Sell
10,809
-133
-1% -$10.2K 0.07% 223
2023
Q2 		$843K Buy
10,942
+63
+0.6% +$5.03K 0.07% 227
2023
Q1 		$903K Sell
10,879
-1,583
-13% -$131K 0.08% 213
2022
Q4 		$1.06M Buy
12,462
+178
+1% +$14.1K 0.1% 184
2022
Q3 		$759K Buy
12,284
+5,886
+92% +$371K 0.08% 222
2022
Q2 		$397K Buy
6,398
+361
+6% +$22.4K 0.04% 328
2022
Q1 		$359K Sell
6,037
-78
-1% -$4.99K 0.03% 368
2021
Q4 		$443K Buy
6,115
+523
+9% +$36K 0.04% 316
2021
Q3 		$390K Buy
5,592
+113
+2% +$7.94K 0.04% 339
2021
Q2 		$376K Sell
5,479
-963
-15% -$64.3K 0.04% 342
2021
Q1 		$416K Buy
6,442
+2,091
+48% +$135K 0.04% 313
2020
Q4 		$253K Sell
4,351
-2,685
-38% -$162K 0.03% 389
2020
Q3 		$443K Sell
7,036
-945
-12% -$65.5K 0.06% 234
2020
Q2 		$614K Sell
7,981
-2,141
-21% -$164K 0.09% 206
2020
Q1 		$757K Sell
10,122
-1,892
-16% -$131K 0.13% 154
2019
Q4 		$779K Buy
12,014
+916
+8% +$59.7K 0.1% 165
2019
Q3 		$703K Buy
11,098
+2,001
+22% +$131K 0.1% 173
2019
Q2 		$616K Sell
9,097
-2,256
-20% -$148K 0.1% 178
2019
Q1 		$736K Buy
11,353
+286
+3% +$19K 0.12% 156
2018
Q4 		$692K Buy
11,067
+2,587
+31% +$181K 0.12% 148
2018
Q3 		$655K Buy
8,480
+822
+11% +$62.1K 0.1% 165
2018
Q2 		$543K Sell
7,658
-311
-4% -$22K 0.09% 174
2018
Q1 		$602K Sell
7,969
-1,117
-12% -$88.8K 0.11% 150
2017
Q4 		$652K Sell
9,086
-1,670
-16% -$127K 0.12% 136
2017
Q3 		$872K Buy
10,756
+1,251
+13% +$95.7K 0.17% 106
2017
Q2 		$673K Buy
9,505
+2,096
+28% +$139K 0.13% 128
2017
Q1 		$504K Buy
7,409
+2,823
+62% +$199K 0.1% 155
2016
Q4 		$329K Sell
4,586
-230
-5% -$17.1K 0.07% 181
2016
Q3 		$381K Sell
4,816
-76
-2% -$6.17K 0.09% 162
2016
Q2 		$409K Buy
4,892
+1,198
+32% +$106K 0.09% 154
2016
Q1 		$339K Buy
3,694
+102
+3% +$9.2K 0.09% 164
2015
Q4 		$363K Sell
3,592
-30
-0.8% -$3.12K 0.1% 148
2015
Q3 		$356K Buy
3,622
+477
+15% +$53K 0.1% 146
2015
Q2 		$368K Sell
3,145
-221
-7% -$24.1K 0.09% 163
2015
Q1 		$331K Sell
3,366
-1,026
-23% -$104K 0.08% 170
2014
Q4 		$413K Sell
4,392
-504
-10% -$52.1K 0.11% 154
2014
Q3 		$522K Buy
4,896
+200
+4% +$19.6K 0.14% 128
2014
Q2 		$388K Buy
4,696
+684
+17% +$53.2K 0.08% 158
2014
Q1 		$284K Sell
4,012
-290
-7% -$22.7K 0.07% 183
2013
Q4 		$324K Hold
4,302
– – 0.09% 181
2013
Q3 		$271K Buy
+4,302
New +$257K 0.08% 194

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dorsey & Whitney Trust's GILD Position: Q1 2026 in Review

Dorsey & Whitney Trust increased its Gilead Sciences (GILD) stake by 1.3% in Q1 2026, buying an estimated $23.5K and bringing the position to 13,273 shares worth $1.85M. The position accounts for 0.1% of the portfolio, ranked #184.

Dorsey & Whitney Trust first reported a position in GILD in Q3 2013 and has held it in 51 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Dorsey & Whitney Trust held 13,273 shares of Gilead Sciences worth $1.85M as of Q1 2026.
  • Dorsey & Whitney Trust bought 168 Gilead Sciences shares in Q1 2026, an estimated $23.5K.
  • Gilead Sciences made up 0.1% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #184 holding.
  • Dorsey & Whitney Trust first reported a position in Gilead Sciences in Q3 2013 and has held it in 51 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.